---
title: 'Long-term Risk of Prostate Cancer Mortality Among Men with Baseline Prostate-specific
  Antigen Below 3 ng/ml: Evidence from the Finnish Randomized Study of Screening for
  Prostate Cancer'
date: '2024-12-06'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39643505/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241207173203&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS AND CLINICAL IMPLICATIONS: Our findings highlight the importance
  of a nuanced approach to PSA in PCa screening, suggesting utility for combining
  PSA with other tests at low levels and indicating minimal risk associated with discontinuing
  screening at ages 67-71 yr when PSA is ...'
disable_comments: true
---
CONCLUSIONS AND CLINICAL IMPLICATIONS: Our findings highlight the importance of a nuanced approach to PSA in PCa screening, suggesting utility for combining PSA with other tests at low levels and indicating minimal risk associated with discontinuing screening at ages 67-71 yr when PSA is ...